LUMOS PHARMA, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Lumos Pharma, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2012 to Q3 2024.
  • Lumos Pharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $379K, a 32.2% decline year-over-year.
  • Lumos Pharma, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $1.87M, a 21.6% decline year-over-year.
  • Lumos Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $2.32M, a 0.09% increase from 2022.
  • Lumos Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.32M, a 19.4% decline from 2021.
  • Lumos Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.88M, a 168% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.87M $379K -$180K -32.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $2.05M $387K -$266K -40.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 $2.32M $580K -$6K -1.02% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $2.32M $524K -$63K -10.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 $2.39M $559K -$34K -5.73% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $2.42M $653K +$78K +13.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 $2.34M $586K +$21K +3.72% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $2.32M $587K +$93K +18.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 $2.23M $593K +$103K +21% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $2.12M $575K -$271K -32% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $2.4M $565K -$484K -46.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $2.88M $494K +$176K +55.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-07
Q3 2021 $2.7M $490K +$185K +60.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $2.52M $846K +$572K +209% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $1.95M $1.05M +$872K +493% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 $1.07M $318K +$271K +577% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 $803K $305K +$261K +593% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $542K $274K +$234K +585% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $308K $177K +$129K +269% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $179K $47K -$3.45M -98.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-09
Q3 2019 $3.63M $44K -$4.56M -99% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $8.19M $40K -$4.16M -99% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $12.3M $48K -$4.75M -99% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-02
Q4 2018 $17.1M $3.5M -$100K -2.78% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-03
Q3 2018 $17.2M $4.6M +$200K +4.55% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $17M $4.2M -$400K -8.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $17.4M $4.8M -$1.1M -18.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $18.5M $3.6M $0 0% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-03
Q3 2017 $18.5M $4.4M +$500K +12.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-02
Q2 2017 $18M $4.6M +$100K +2.22% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 $17.9M $5.9M +$1.2M +25.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $16.7M $3.6M +$100K +2.86% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-05
Q3 2016 $16.6M $3.9M +$600K +18.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 $16M $4.5M -$1.4M -23.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $17.4M $4.7M +$1.5M +46.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 $15.9M $3.5M +$1.8M +106% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-05
Q3 2015 $14.1M $3.3M $0 0% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 $14.1M $5.9M +$4.4M +293% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $9.7M $3.2M +$1.1M +52.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-29
Q4 2014 $8.6M $1.7M +$466K +37.8% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-06
Q3 2014 $8.13M $3.3M +$2.2M +200% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $5.93M $1.5M +$400K +36.4% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 $5.53M $2.1M +$1.13M +117% Jan 1, 2014 Mar 31, 2014 10-Q/A 2015-08-24
Q4 2013 $4.4M $1.23M +$599K +94.3% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $3.8M $1.1M +$471K +74.9% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $3.33M $1.1M -$100K -8.33% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 $3.43M $966K +$230K +31.3% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $3.2M $635K Oct 1, 2012 Dec 31, 2012 10-K 2015-03-16
Q3 2012 $629K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $1.2M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 $736K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.